‘Engaging the private sector is important to prevent TB spread’
Dr Evan Lee, Vice President of Global Health Programs, Eli Lilly talks to Viveka Roychowdhury about the role of private players to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
‘It is important to listen to, respect the patient’s voice’
Blessina Kumar, Delhi-based health activist and public health consultant spoke to Viveka Roychowdhury on the crucial need to make…
‘Media and the TB control sector time to build a relationship’
Bharathi Ghanashyam, from Journalists against TB outlines the reasons why TB ranks very low with the media
‘Preventing drug-resistant TB in India’
Madhukar Pai, Professor, McGill University, Montreal, Canada says a trans-formational change in the relationship between the…
’Pharmacists: an untapped potential in TB care and control’
Manjiri Gharat, Vice-President and Chairperson, Indian Pharmaceutical Association-Community Pharmacy Division (IPA CPD) speaks to…
‘Response to TB in India needs bold policies’
Dr Suvanand Sahu, Team Leader for TB-REACH, Stop TB Partnership presents seven points important to address TB and prevent further…
TB diagnosis in India Challenges and opportunities
Dr Sanjay Sarin, Regional Director, Global Health (Central & South Asia Pacific), BD elaborates on the challenges and…
Epidemiology of TB in India
Dr Giridhar R Babu, Associate Professor, Public Health Foundation of India discusses the imminent need for improved diagnostics…
Glenmark confirms patent challenge for its generic version of FINACEA
Is indicated for the topical treatment of inflammatory papules and pustules of mild to moderate rosacea
FDA VS CHEMISTS An Ongoing Battle
Food and Drug Administration (FDA) Maharashtra and chemists across the state have once again locked horns over the issue of…